Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

This study has been terminated.
(Interim analysis of efficacy trial showed no drug efficacy.)
Sponsor:
Collaborator:
Collaborative Study Group (CSG)
Information provided by (Responsible Party):
Keryx Biopharmaceuticals
ClinicalTrials.gov Identifier:
NCT00462202
First received: April 16, 2007
Last updated: November 29, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)